GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.

Background: The duration of protection after hepatitis B vaccination of infants is unknown. Methods: We determined antibody to hepatitis B surface antigen (anti-HBs) at 4-13 years of age in 363 ...

Hepatitis B is inflammation of the liver in hominoidea, including humans, caused by the hepatitis B virus. The virus is transmitted by parenteral exposure, such as by exposure to infectious blood ...

The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...

Researchers update clinical practice guidelines for how to prevent and monitor hepatitis B virus reactivation.

The Philadelphia Department of Public Health has released its 2023 Annual Report on Hepatitis B, C, and D in the city. The ...

Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths ...

Hepatitis B (sometimes referred to as hep B) is a liver infection caused by the hepatitis B virus (HBV). It typically causes symptoms like stomach pain, dark urine, fatigue, fever, jaundice (yellowing ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

Chronic hepatitis B virus (HBV) infection imposes a severe burden on global public health. Currently, there are no curative therapies for millions of chronic HBV-infected patients (Lok et al., 2017).

Introduction: For complete or functional cure of hepatitis B virus (HBV) infection, application of immunotherapy is now being attempted. Recently, we reported that a 6-mer hepatitis B virus ...